105310-25-6

• 

• Basic information

  1. Product Name: (1R,2S)-N,N-diethyl-2-[(glycylamino)methyl]-1-phenylcyclopropanecarboxamide
  2. Synonyms:
  3. CAS NO:105310-25-6
  4. Molecular Formula: C₁₇H₂₅N₃O₂
  5. Molecular Weight: 303.3993
  6. EINECS: N/A
  7. Product Categories: N/A
  8. Mol File: 105310-25-6.mol
  9. Article Data: 1

• Chemical Properties

  1. Melting Point: N/A
  2. Boiling Point: 527.4°C at 760 mmHg
  3. Flash Point: 272.7°C
  4. Appearance: N/A
  5. Density: 1.133g/cm³
  6. Vapor Pressure: 3.28E-11mmHg at 25°C
  7. Refractive Index: 1.556
  8. Storage Temp.: N/A
  9. Solubility: N/A
  10. CAS DataBase Reference: (1R,2S)-N,N-diethyl-2-[(glycylamino)methyl]-1-phenylcyclopropanecarboxamide(CAS DataBase Reference)
  11. NIST Chemistry Reference: (1R,2S)-N,N-diethyl-2-[(glycylamino)methyl]-1-phenylcyclopropanecarboxamide(105310-25-6)
  12. EPA Substance Registry System: (1R,2S)-N,N-diethyl-2-[(glycylamino)methyl]-1-phenylcyclopropanecarboxamide(105310-25-6)

• Safety Data

  1. Hazard Codes: N/A
  2. Statements: N/A
  3. Safety Statements: N/A
  4. WGK Germany:
  5. RTECS:
  6. HazardClass: N/A
  7. PackingGroup: N/A
  8. Hazardous Substances Data: 105310-25-6(Hazardous Substances Data)

• Suppliers
• Usage
• SDS
• Upstream product
• Downstream Products
• Article

105310-25-6 Suppliers

Recommended suppliersmore

• Product
• FOB Price
• Min.Order
• Supply Ability
• Supplier
• Contact Supplier

105310-25-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 105310-25-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,3,1 and 0 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 105310-25:
(8*1)+(7*0)+(6*5)+(5*3)+(4*1)+(3*0)+(2*2)+(1*5)=66
66 % 10 = 6
So 105310-25-6 is a valid CAS Registry Number.

105310-25-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name	(1R,2S)-2-[[(2-aminoacetyl)amino]methyl]-N,N-diethyl-1-phenylcyclopropane-1-carboxamide

1.2 Other means of identification

Product number	-
Other names	-

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105310-25-6 SDS

105310-25-6Upstream product

• 105310-95-0 (1R,2S)-2-{[2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-acetylamino]-methyl}-1-phenyl-cyclopropanecarboxylic acid diethylamide 
• 105310-75-6 (1SR,2RS)-2-((1,3-dioxoisoindolin-2-yl)methyl)-N,N-diethyl-1-phenylcyclopropane carboxamide 
• 105310-09-6 milnacipran 
• 105310-90-5 (Z)-1-phenyl-2-(bromomethyl)-N,N-diethylcyclopropanecarboxamide 
• 105310-66-5 (1S,2R)/(1R,2S)-2-(bromomethyl)-1-phenylcyclopropanecarboxylic acid chloride 
• 69160-63-0 (1S,2R)/(1R,2S)-2-(bromomethyl)-1-phenylcyclopropanecarboxylic acid 

105310-25-6Downstream Products

105310-25-6Relevant articles and documents

1-Aryl-2-(aminomethyl)cyclopropanecarboxylic Acid Derivatives. A New Series of Potential Antidepressants

Bonnaud, Bernard,Cousse, Henri,Mouzin, Gilbert,Briley, Mike,Stenger, Antoine,et al.

, p. 318 - 325 (2007/10/02)

A series of 1-aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives were synthesized and evaluated as potential antidepressants.Compounds with the Z configuration were synthesized from 1-aryl-2-oxo-3-oxabicyclohexane and those with E configuration from (E)-1-phenyl-2-(hydroxymethyl)cyclopropanecarboxylic acid.The compounds were evaluated in animal tests designed to reveal potential antidepressant activity and the existence of undesirable side effects.Several derivatives were more active than imipramine and desipramine.On the basis of its activity in pharmacological animal tests of antidepressant activity and its potential lack of side effects, 1-phenyl-1--2-(aminomethyl)cyclopropane hydrochloride, midalcipran (INN), was selected for further development.This compound is currently in phase III clinical evaluation.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Please select Metric Ton KG G Pound L ML

Email:

Company name:

Valid Period:

Detailed Requirements:

• Sample
• MOQ
• GMP
• FDA
• Price
• Urgent purchase

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Remove

Submit

1

What can I do for you?
Get Best Price

Get Best Price for 105310-25-6 (1R,2S)-N,N-diethyl-2-[(glycylamino)methyl]-1-phenylcyclopropanecarboxamide

Send

Send

Metric Ton KG G Pound L ML

Send

Send